ZA200604410B - Imidazole derivatives, processes for preparing them and their uses - Google Patents
Imidazole derivatives, processes for preparing them and their usesInfo
- Publication number
- ZA200604410B ZA200604410B ZA200604410A ZA200604410A ZA200604410B ZA 200604410 B ZA200604410 B ZA 200604410B ZA 200604410 A ZA200604410 A ZA 200604410A ZA 200604410 A ZA200604410 A ZA 200604410A ZA 200604410 B ZA200604410 B ZA 200604410B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparing
- processes
- imidazole derivatives
- pharmaceuticals
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Resins (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03027614 | 2003-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200604410B true ZA200604410B (en) | 2008-09-25 |
Family
ID=34639269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200604410A ZA200604410B (en) | 2003-12-02 | 2004-11-29 | Imidazole derivatives, processes for preparing them and their uses |
Country Status (16)
Country | Link |
---|---|
US (2) | US7244747B2 (ja) |
EP (2) | EP1706376B1 (ja) |
JP (1) | JP2007513105A (ja) |
KR (1) | KR20060110349A (ja) |
CN (1) | CN1906160A (ja) |
AT (1) | ATE424384T1 (ja) |
AU (1) | AU2004295083B2 (ja) |
BR (1) | BRPI0417157A (ja) |
CA (1) | CA2546970C (ja) |
DE (1) | DE602004019814D1 (ja) |
EA (1) | EA010031B1 (ja) |
ES (1) | ES2323313T3 (ja) |
MX (1) | MXPA06006026A (ja) |
NO (1) | NO20063062L (ja) |
WO (1) | WO2005054188A1 (ja) |
ZA (1) | ZA200604410B (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1718756B1 (en) * | 2004-02-24 | 2011-11-16 | Allergan, Inc. | Botulinum toxin screening assays |
EP1912966A2 (en) | 2005-06-01 | 2008-04-23 | Ucb, S.A. | 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
MY143249A (en) * | 2005-09-15 | 2011-04-15 | Ucb Pharma Sa | 4-substituted pyrrolidin-2-ones and their use |
TWI386405B (zh) | 2006-09-05 | 2013-02-21 | 咪唑衍生物 | |
WO2008132139A2 (en) * | 2007-04-27 | 2008-11-06 | Ucb Pharma S.A. | New heterocyclic derivatives useful for the treatment of cns disorders |
EP2017273A1 (en) * | 2007-07-18 | 2009-01-21 | Laboratorios del Dr. Esteve S.A. | Process for the enantioselective preparation of pregabalin |
US7883745B2 (en) | 2007-07-30 | 2011-02-08 | Micron Technology, Inc. | Chemical vaporizer for material deposition systems and associated methods |
CA2722159C (en) * | 2008-04-24 | 2016-04-05 | Newlink Genetics Corporation | Substituted phenylimidazole compounds and their use as ido inhibitors |
ES2637497T3 (es) | 2008-10-16 | 2017-10-13 | The Johns Hopkins University | Procedimientos y composiciones para la mejora de la función cognitiva |
EP2461808A2 (en) * | 2009-08-07 | 2012-06-13 | UCB Pharma S.A. | Methods for enhancing the cognitive function |
ME02355B (me) | 2009-10-23 | 2016-06-20 | Ucb Biopharma Sprl | Derivati 2-0ks0-1-pirolidinil imidazotiadiazola |
WO2011100373A1 (en) * | 2010-02-09 | 2011-08-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US8680098B2 (en) | 2010-03-05 | 2014-03-25 | Janssen Pharmaceutica, Nv | Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
RS54487B1 (en) | 2011-04-18 | 2016-06-30 | Ucb Biopharma Sprl | 2-OXO-1-IMIDAZOLIDINIL DERIVATIVES IMIDAZOTIADIAZOL |
WO2014012563A1 (en) * | 2012-07-20 | 2014-01-23 | Ucb Pharma, S.A. | Compounds for enhancing the cognitive function |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
CN106061504B (zh) | 2014-01-21 | 2019-09-06 | 詹森药业有限公司 | 包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途 |
KR20200126026A (ko) | 2014-01-21 | 2020-11-05 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
RU2654065C1 (ru) * | 2017-03-16 | 2018-05-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Уфимский государственный нефтяной технический университет" | Способ получения N-оксиметиламинов |
CN106866494A (zh) * | 2017-03-20 | 2017-06-20 | 安徽金鼎医药股份有限公司 | 一种格列齐特中间体八氢环戊烷并[c]吡咯的制备方法 |
US20240132513A1 (en) | 2022-08-19 | 2024-04-25 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903110A (en) | 1972-04-27 | 1975-09-02 | Gaf Corp | N-(2-pyrrolidinonyl) methyl carbamate derivatives |
AT352119B (de) * | 1975-07-29 | 1979-09-10 | Celamerck Gmbh & Co Kg | Verfahren zur herstellung neuer imidazol-bzw. triazolderivate |
GB1582351A (en) * | 1977-02-10 | 1981-01-07 | Ucb Sa | Disubstituted ureas and thioureas |
US4178167A (en) * | 1977-06-16 | 1979-12-11 | Gaf Corporation | Herbicidal N-(haloacetyl)-N-(N'-methylenepyrrolidonyl)-2-alkoxyanilines useful as herbicides |
GB8412358D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
AU2869092A (en) * | 1991-10-11 | 1993-05-03 | Smithkline Beecham Corporation | Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production |
JPH06220044A (ja) * | 1991-12-25 | 1994-08-09 | Mitsubishi Kasei Corp | ベンズアミド誘導体 |
DE69716900T2 (de) * | 1996-04-10 | 2003-07-03 | Merck & Co., Inc. | Alpha v Beta 3 ANTAGONISTEN |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
-
2004
- 2004-11-29 DE DE602004019814T patent/DE602004019814D1/de active Active
- 2004-11-29 EP EP04819628A patent/EP1706376B1/en active Active
- 2004-11-29 ES ES04819628T patent/ES2323313T3/es active Active
- 2004-11-29 BR BRPI0417157-8A patent/BRPI0417157A/pt not_active IP Right Cessation
- 2004-11-29 JP JP2006541856A patent/JP2007513105A/ja active Pending
- 2004-11-29 CN CNA2004800411465A patent/CN1906160A/zh active Pending
- 2004-11-29 KR KR1020067013297A patent/KR20060110349A/ko not_active Application Discontinuation
- 2004-11-29 AT AT04819628T patent/ATE424384T1/de not_active IP Right Cessation
- 2004-11-29 MX MXPA06006026A patent/MXPA06006026A/es active IP Right Grant
- 2004-11-29 CA CA2546970A patent/CA2546970C/en not_active Expired - Fee Related
- 2004-11-29 ZA ZA200604410A patent/ZA200604410B/xx unknown
- 2004-11-29 EP EP08105960A patent/EP2050736A1/en not_active Withdrawn
- 2004-11-29 EA EA200601065A patent/EA010031B1/ru not_active IP Right Cessation
- 2004-11-29 WO PCT/EP2004/013516 patent/WO2005054188A1/en active Application Filing
- 2004-11-29 AU AU2004295083A patent/AU2004295083B2/en not_active Ceased
- 2004-11-30 US US10/999,217 patent/US7244747B2/en not_active Expired - Fee Related
-
2006
- 2006-06-30 NO NO20063062A patent/NO20063062L/no not_active Application Discontinuation
-
2007
- 2007-06-11 US US11/808,558 patent/US7763644B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE602004019814D1 (de) | 2009-04-16 |
EP1706376B1 (en) | 2009-03-04 |
KR20060110349A (ko) | 2006-10-24 |
US7244747B2 (en) | 2007-07-17 |
AU2004295083B2 (en) | 2010-08-19 |
WO2005054188A1 (en) | 2005-06-16 |
EP2050736A1 (en) | 2009-04-22 |
US20080081832A1 (en) | 2008-04-03 |
CA2546970C (en) | 2011-04-26 |
JP2007513105A (ja) | 2007-05-24 |
EA200601065A1 (ru) | 2006-12-29 |
CA2546970A1 (en) | 2005-06-16 |
NO20063062L (no) | 2006-08-30 |
EP1706376A1 (en) | 2006-10-04 |
US7763644B2 (en) | 2010-07-27 |
AU2004295083A1 (en) | 2005-06-16 |
MXPA06006026A (es) | 2006-08-23 |
EA010031B1 (ru) | 2008-06-30 |
ES2323313T3 (es) | 2009-07-13 |
BRPI0417157A (pt) | 2007-03-06 |
CN1906160A (zh) | 2007-01-31 |
US20050137241A1 (en) | 2005-06-23 |
ATE424384T1 (de) | 2009-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063062L (no) | Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
TW200732323A (en) | Organic compounds | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
TW200738659A (en) | Novel compounds | |
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
SE0200920D0 (sv) | Novel compounds | |
TW200833326A (en) | Chemical compounds 572 | |
HK1113790A1 (en) | Selurampanel | |
GB0130341D0 (en) | Compounds | |
MXPA06000921A (es) | Derivados de benzamidazoles como inhibidores de mek. | |
ATE332301T1 (de) | Antivirale pyrazolopyridin verbindungen | |
JO2734B1 (en) | Organic compounds | |
WO2007065595A3 (en) | Xanthine derivatives, processes for preparing them and their uses | |
TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
TWI268278B (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses | |
DE602004024213D1 (en) | Aminopropanolderivate | |
WO2004100865A3 (en) | New benzimidazole derivatives | |
MXPA05012679A (es) | Nuevos derivados de imidazoles, su preparacion y su uso como medicamento. | |
WO2004087652A3 (en) | Imidazotriazine compounds | |
AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
MX2007010841A (es) | 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos. | |
WO2004072037A8 (en) | 2,3'-bipyridines derivatives as selective cox-2 inhibitors |